Category: Impacting News
Inovio Received $71 Million in Funding from the U.S. Department of Defense
Inovio Received US DoD Funding for CELLECTRA® 3PSP Smart Device Inovio ( INO ) announced today it has received $71 million in funding from the U.S. Department of Defense (DoD) to support the large-scale manufacture of the company's proprietary CELLECTRA®...
Read More
June 23, 2020
0
The COVID-19 Vaccines' Developing Firms' Bizarre Evaluations
Novel Coronavirus Vaccines and Wall Street Vaccines against novel coronavirus are recognized now as the only way to return disrupted human lives back to normal. Vaccines have become the most important topic for Wall Street’s investors and analysts especially at...
Read More
June 26, 2020
0
We Are Not Yet in Bizarro World
Unclear Reasoning for the Inovio Selloff Though Inovio ( INO ) announced positive interim clinical data of INO-4800 (its vaccine candidate against novel coronavirus (SARS-CoV-2)) from the first of two Phase 1 clinical trial cohorts, the stock still fell around...
Read More
June 30, 2020
0
Prohost Biotech's Decision About Akero Therapeutics
Akero Therapeutics Today we posted good news from Akero Therapeutics ( AKRO ) under News & Comments . The news was about results from Phase 2a BALANCED study of the firm’s product efruxifermin (EFX), for patients with nonalcoholic steatohepatitis (...
Read More
July 1, 2020
0
Impacting News
In This Column Every day thousands of press releases are issued about biotechnology and pharmaceutical firms. Only a few of these press releases have any impact, whether it be positive or negative, on the firms' that are the subject of...
Read More
August 6, 2019
0
Why Compugen is a Favorite Biotechnology Firm
Compugen Compugen ( CGEN ) presented its third-quarter achievements and financial results. We believe the firm is on the right track towards clinically confirming that its discovered targets, PVRIG and TIGIT when inhibited, will extend the capability of the current...
Read More
November 6, 2020
0
CRiSPR Therapeutics Stock is Skyrocketing
CRiSPR Therapeutics Rally For those who wonder why CRiSPR Therapeutics ( CRSP ) is soaring we remind that they should have been expecting this rally and for it to be followed by its two sisters Intellia Therapeutics ( NTLA )...
Read More
July 8, 2020
0
CRISPR Therapeutics - Professor Emmanuelle Charpentier - Gene Editing and the Future of Humanity
CRISPR Therapeutics Dr. Emmanuelle Charpentier, Co-Founder CRISPR Therapeutics ( CRSP ) announced on October 7, 2020 that Dr. Emmanuelle Charpentier has been awarded the 2020 Nobel Prize in Chemistry for her groundbreaking work on the CRISPR/Cas9 system. Dr. Emmanuelle Charpentier...
Read More
November 6, 2020
0
A New Gene Therapy Series Starts Today with Regenxbio
Beyond the firms that are speeding towards bringing prophylactic vaccines against the COVID-19 infection into the clinic we have to consider the other firms that have been negatively affected by the virus pandemic; we expect them to rebound and surge...
Read More
July 16, 2020
0
Nektar Therapeutics Q2 Results for 2019 Press Release
Nektar Press Release Nektar Therapeutics Results for Q2 of 2019 Nektar Therapeutics (Nasdaq: NKTR ) reported its financial results for the second quarter ended June 30, 2019. Cash and investments in marketable securities at June 30, 2019 were $1.8 billion as compared to $1.9 billion at December 31, 2018. ...
Read More
August 9, 2019
0
Search ProhostBiotech
Popular Links
23andMe Holding Co (ME)Abbott Laboratories (ABT)AbbVie Inc (ABBV)AbCelleraAbeona Therapeutics (ABEO)Ablynx (ABLX)AbVitro IncAcadia (ACAD)Acceleron Pharma (XLRN)AcelRx Pharmaceuticals (ACRX).Acorda Therapeutics Inc (ACOR)Acumen Pharmaceuticals (ABOS)AdaptImmune Therapeutics (ADAP)Adaptive BiotechnologiesADC Therapeutics (ADCT)Adimab LLCAdvanced Micro Devices (AMD)Advaxis (ADXS)Adverum Biotechnologies (ADVM)Aerie Pharmaceuticals (AERI)AgenTus TherapeuticsAgenus (AGEN)AgeX Therapeutics (AGE)Agilent Technologies (A)Agilis Biotherapeutics IncAgios Pharmaceuticals (AGIO)AIM ImmunoTech (AIM)Aimmune Therapeutics (AIMT)Akari Therapeutics (AKTX)Akashi TherapeuticsAkcea Therapeutics (AKCA)Akebia Therapeutics Inc (AKBA)Akero Therapeutics (AKRO)Akous Inc (a wholly owned subsidiary of Eli Lilly Company)Alder BioPharmaceuticals (ALDR)Alexion Pharmaceuticals (ALXN)Alkermes (ALKS)Allergan Plc (AGN)Allogene TherapeuticsAllogene Therapeutics (ALLO)